Stay updated on Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.

Latest updates to the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page
- Check10 days agoChange DetectedThe web page has been updated from version v2.16.2 to v2.16.3.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check32 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check54 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check68 days agoChange DetectedThe page has been updated to include new identifiers and collaborators, specifically mentioning Bristol-Myers Squibb, while significant details about the study's purpose and criteria have been removed.SummaryDifference8%
Stay in the know with updates to Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Urothelial Cancer Clinical Trial page.